CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age (Co-administered With Infanrix®) in Primed Healthy Toddlers.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00614614
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:09.099635+00:00
Published At: 2012-07-20T00:00:00+00:00
Record Updated At: 2018-09-21
Results Posted At: 2012-07-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-21"
protocolSection.identificationModule.nctId: "NCT00614614"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals\u0027 Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age (Co-administered With Infanrix\u00ae) in Primed Healthy Toddlers."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2012-07-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.